Opinion|Videos|June 25, 2024
Empowering Patients: Understanding New Treatments and Long-Term Considerations with Fresh Approaches and FDA Endorsements
Author(s)Kristine Kucera, PA-C, MPAS, DHS , Mickey Bryson
Mickey Bryson recounts how Kristine Kucera, PA-C, MPAS, DHS, introduced a new medication and shared trial data with him, empowering him to make an informed decision about trying the new treatment.
Advertisement
Episodes in this series
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Related Content
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
AbbVie Files for Vitiligo Indication, Putting Systemic Therapy Under Regulatory Review
2
Icotrokinra Shows Superior Efficacy Over Advanced Oral Therapies in New Psoriasis Meta-Analysis
3
FDA Accepts Galderma’s BLA Resubmission for Liquid Neuromodulator RelabotulinumtoxinA
4
Nutrafol Expands Portfolio with First and Only Hair Loss Supplement for Male Patients 50 and Older
5